Invention Grant
- Patent Title: Nuclear transport modulators and uses thereof
-
Application No.: US15831048Application Date: 2017-12-04
-
Publication No.: US10335393B2Publication Date: 2019-07-02
- Inventor: Vincent Sandanayaka , Sharon Shechter , Sharon Shacham , Dilara McCauley , Erkan Baloglu
- Applicant: Biogen MA Inc.
- Applicant Address: US MA Cambridge
- Assignee: Biogen MA Inc.
- Current Assignee: Biogen MA Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Foley Hoag LLP
- Main IPC: C07D413/12
- IPC: C07D413/12 ; C07D403/12 ; C07D401/12 ; C07D401/10 ; C07D249/08 ; A61K31/5377 ; A61K31/497 ; A61K31/454 ; A61K31/4196 ; A61K45/06
Abstract:
The present invention relates to compounds of formula I: and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising the compounds of formula I, and methods of using the compounds, salts and compositions in the treatment of various disorders associated with CRM1 activity.
Public/Granted literature
- US20180289675A1 NUCLEAR TRANSPORT MODULATORS AND USES THEREOF Public/Granted day:2018-10-11
Information query
